scholarly journals Intranasal and sublingual delivery of inactivated polio vaccine

Vaccine ◽  
2017 ◽  
Vol 35 (20) ◽  
pp. 2647-2653 ◽  
Author(s):  
Heleen Kraan ◽  
Peter Soema ◽  
Jean-Pierre Amorij ◽  
Gideon Kersten
2014 ◽  
Vol 31 (10) ◽  
pp. 2618-2629 ◽  
Author(s):  
Heleen Kraan ◽  
Paul van Herpen ◽  
Gideon Kersten ◽  
Jean-Pierre Amorij

2011 ◽  
Vol 18 (8) ◽  
pp. 1387-1390 ◽  
Author(s):  
Diana Kouiavskaia ◽  
Marc S. Collett ◽  
Eugenia M. Dragunsky ◽  
Andrey Sarafanov ◽  
Konstantin M. Chumakov

ABSTRACTImmunization of mice with inactivated polio vaccine (IPV) with concurrent dosing of poliovirus antiviral V-073 showed no detrimental impact on the elicitation of serum-neutralizing antibodies. A strategy involving coadministration of antiviral V-073 and IPV can be considered for the management of poliovirus incidents.


2015 ◽  
Vol 11 (12) ◽  
pp. e1005316 ◽  
Author(s):  
Sarah Knowlson ◽  
John Burlison ◽  
Elaine Giles ◽  
Helen Fox ◽  
Andrew J. Macadam ◽  
...  

2018 ◽  
Vol 67 (suppl_1) ◽  
pp. S57-S65 ◽  
Author(s):  
James T Gaensbauer ◽  
Chris Gast ◽  
Ananda S Bandyopadhyay ◽  
Miguel O’Ryan ◽  
Xavier Saez-Llorens ◽  
...  

Vaccine ◽  
2020 ◽  
Vol 38 (21) ◽  
pp. 3780-3789
Author(s):  
Xavier Sáez-Llorens ◽  
Birgit Thierry-Carstensen ◽  
Lina Saem Stoey ◽  
Charlotte Sørensen ◽  
Henrik Wachmann ◽  
...  

2020 ◽  
Vol 35 (Supplement_1) ◽  
pp. i30-i37
Author(s):  
Mirembe Rachel Faith ◽  
Babirye Juliet ◽  
Nathan Tumuhamye ◽  
Tumwebaze Mathias ◽  
Emma Sacks

Abstract Uganda officially introduced the inactivated polio vaccine (IPV) in May 2016 as part of the polio eradication strategy and integrated it into its routine immunization programme in addition to the oral polio vaccine. The current coverage stands at 60% as of July 2017. We therefore aimed to determine factors associated with the uptake of IPV among children in Kalungu District so as to inform the implementation of the vaccine policy. A community-based cross-sectional study was conducted among caregivers of 406 eligible children aged 12–23 months through multi-stage systematic sampling and a standardized semi-structured questionnaire. Nine key informant interviews were conducted through purposive selection of health care providers and members of Village Health Teams (VHTs) based on their expertize. Modified Poisson regression and thematic content analysis were used to determine factors significant to IPV uptake among children. 71% of sampled children aged 12–23 months had received IPV in Kalungu District. The survey found that being encouraged by health workers and VHTs was significant to children’s uptake of IPV (Adjusted PR 1.24, 95% CI; 1.22–3.47). Distance to the immunization point (Adjusted PR 0.32,95% CI; 0.16–0.62) and caregiver’s education level (Adjusted PR 1.16,95% CI; 1.05–2.22) were also associated with IPV uptake. Qualitative findings from health workers and VHT members further confirmed the perception that distance to the immunization post was important, and VHTs also stated that being encouraged by health workers was critical to IPV uptake. The current prevalence of IPV uptake among children aged 12–23 months in Kalungu is 71%, higher than the last reported national coverage (60%), though still below the recommended national coverage of 95%. Efforts should be focused on sensitization of caregivers through health workers and VHTs. Immunization outreach should be strengthened so as to bring services closer to patients.


Sign in / Sign up

Export Citation Format

Share Document